New trials are published on a daily basis following impact of COVID-19 on the health of the individuals, scientific works are focused on the epidemics, patophysiology, clinical features and treatment of COVID-19. There is a big question about long-term impact after recovering from this condition. COVID-19 seems to be connected with worse prognosis and higher mortality within patients with pre-existing cardiovascular diseases. On the other hand COVID-19 itselfs might induce myocardial injury , arrhytmias, acute coronary syndrome and venous thromboembolism. Not negligible are concerns about possible interactions between COVID-19 treatment and cardiovascular medications. We summarize and refer available information about pathophysiology, epidemiology, clinical features and possible treatment focusing on cardiovascular system.

Key words: COVID-19, cardiovascular system, SARS-CoV-2.
Lek Obz, 2021, 70 (10): 356-363

Katarína HRICOVÁ 1,4, Soňa TOMKOVÁ 1,2, Peter JACKULIAK 2 , Daniela ONDUŠOVÁ 3, Natália VAŇOVÁ 1

1 Interná klinika Lekárskej fakulty UPJŠ, Nemocnica AGEL Košice-Šaca, a.s., prednostka MUDr. N. Vaňová, PhD.
2 V. interná klinika Lekárskej fakulty UK a Univerzitnej nemocnice Bratislava, prednosta prof. MUDr. J. Payer, PhD., MPH, FRCP
3 I. kardiologická klinika Lekárskej fakulty UPJŠ, Východoslovenský ústav srdcových a cievnych chorôb, a.s., Košice, prednosta
prof. MUDr. G. Valočik, PhD.
4 Prešovská univerzita v Prešove, Fakulty humanitných a prírodných vied, dekanka: prof. MVDr. J. Poráčová, PhD., MBA

HRICOVÁ K., TOMKOVÁ S., JACKULIAK P., ONDUŠOVÁ D., VAŇOVÁ N.: COVID-19 and cardiovascular system. Lek Obz, 2021, 70 (10): 356-363

Login Form